New insights into the molecular profile of lung adenocarcinoma and implications for therapy

Expert Review of Anticancer Therapy
Bharath GaneshRamaswamy Govindan

Abstract

Lung cancer is a molecularly heterogeneous disease. The advent of next-generation sequencing techniques has significantly advanced our understanding of the complex molecular underpinnings of lung cancer. Furthermore, the development of targeted therapies has significantly altered the landscape of lung cancer therapy over the past decade. There is hence an increasing interest in developing a classification system that guides clinical management and also incorporates relevant genomic information. Here, we highlight the molecular features of lung adenocarcinoma as highlighted by several independent groups, and more recently The Cancer Genome Atlas and discuss their potential clinical significance.

References

Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Neil HayesMatthew Meyerson
Aug 21, 2009·The New England Journal of Medicine·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Nov 8, 2011·Clinics in Chest Medicine·William D Travis
Aug 28, 2012·Science·Gopa IyerDavid B Solit
Sep 11, 2012·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 18, 2012·Cell·Ramaswamy GovindanRichard K Wilson
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jul 3, 2013·The Oncologist·Justin F Gainor, Alice T Shaw
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Oct 29, 2013·Nature Medicine·Aria VaishnaviRobert C Doebele
Jan 29, 2014·Oncogene·A H BergerM Meyerson
Mar 29, 2014·The New England Journal of Medicine·Alice T ShawJeffrey A Engelman
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn
Jul 2, 2014·Nature Reviews. Clinical Oncology·D Ross CamidgeLecia V Sequist
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 1, 2014·Nature Medicine·Christine M LovlyWilliam Pao
Sep 30, 2014·The New England Journal of Medicine·Alice T ShawA John Iafrate
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.